| 胎脾LAK细胞加rIL－2治疗51例中晚期恶性肿瘤临床疗效观察 |
| |
| 引用本文： | 王润田,姜少灏,张红中,姚树坤,周学敏,刘文虎,朱铁年.胎脾LAK细胞加rIL－2治疗51例中晚期恶性肿瘤临床疗效观察[J].河北医科大学学报,1995(1). |
| |
| 作者姓名： | 王润田 姜少灏 张红中 姚树坤 周学敏 刘文虎 朱铁年 |
| |
| 摘 要： | 用胎脾ＬＡＫ细胞加ｒＩＬ－２治疗中晚期恶性肿瘤５１例，其中ＣＲ３例，ＰＲ７例，有效率ＣＲ＋ＰＲ为１９．６％，ＣＲ＋ＰＲ＋ＭＲ为３１．４％。大多数患者临床症状改善，生活质量提高，生存期延长，治疗中未见严重副反应。
|
| 关 键 词： | 胎脾LAK细胞，重组白细胞介素2，过继免疫治疗，肿瘤 |
CLINCAL OBSERVATIONS ON 51 CASES OF MALIGNANT PATIENTS AT MIDDLE AND ADVANCED STAGES TREATED WITH LAK CELLS FROM FETAL SPLENOCYTES PLUS rLL-2 |
| |
| Wang Runtian,Jiang Shaohao,Zhang Hongzhong,Yao ShukunZhou Xuemin,Liu Wenhu,Zhu Tienian,Wang Huifen.CLINCAL OBSERVATIONS ON 51 CASES OF MALIGNANT PATIENTS AT MIDDLE AND ADVANCED STAGES TREATED WITH LAK CELLS FROM FETAL SPLENOCYTES PLUS rLL-2[J].Journal of Hebei Medical University,1995(1). |
| |
| Authors: | Wang Runtian Jiang Shaohao Zhang Hongzhong Yao ShukunZhou Xuemin Liu Wenhu Zhu Tienian Wang Huifen |
| |
| Institution: | Institute of Basic Medicine |
| |
| Abstract: | With LAK cells from fetal splenocytes plus rIL-2,51 cases of malignant patients at the coddle and advanced stages were treated. Of them,3 cases were complete response (CR),7 cases partial response (PR),and curative effects were 19. 6%(CR+PR) or 31.4% (CR+PR+MR).In most of the patients,the clinical symptoms and living quality were improved,and the periods of survival extended. No severe toxic side effects werefound. |
| |
| Keywords: | LAK cells from fetal splenocytes rLL-2 adoptive immunotherapy cancer |
| 本文献已被 CNKI 等数据库收录！ |
